Edge Therapies in Demand

Virionyx – the NZ company behind an experimental new AIDS drug – has been hired by two US organisations to develop therapies for diseases such as SARS. Said PM Helen Clark, at the opening of Virionyx’s new Mangere headquarters; “These developments at Virionyx are a significant step for the NZ biotechnology industry and one that will boost its international profile.” Virionyx is to develop antibody and antiviral treatments for SARS, West Nile virus, dengue fever, smallpox, anthrax, plague, tularaemia, and botulism for the Hauptman-Woodward Medical Research Institute and ZeptoMetrix biotechnology firm.


Tags: AIDS drug  anthrax  China Daily  Hauptman-Woodward Medical Research Institute  Helen Clark  Mangere  New Zealand  NZ biotechnology industry  People's Daily  SARS  smallpox  United States  Virionyx  West Nile virus  ZeptoMetrix  

Weta Digital Receives Significant Investment

Weta Digital Receives Significant Investment

Napster co-founder and former Facebook president Sean Parker has invested in film director Peter Jackson’s Wellington-based visual effects studio, Weta Digital, Fortune magazine reports. Weta Digital has contributed work on a number…